While both drug companies provide warning labels about common side effects of their GLP-1 medications, their labels may not provide adequate warning about severe complications such as stomach paralysis, intestinal blockages, or bowel obstruction
A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients
Tirzepatide (Mounjaro) for type 2 diabetes starts at 2.5 mg once weekly for four weeks, then increases to 5 mg
How Often Should I Feed My Pet
Others are noticing health concerns such as elevated blood sugar, blood pressure, or cholesterol and want a structured plan to address both weight and long-term wellness
Let it cool slightly so its warm, not hot